We recently published a list of 12 Best German Stocks to Buy According to Hedge Funds. In this article, we are going to take ...

With nearly 800 cases adjudicated or pending thus far at the Unified Patent Court (UPC), a possible procedural gap has ...

After the European Commission abruptly withdrew its proposal on Standard Essential Patents (SEPs), several MEPs demand ...

Organizations that develop sophisticated approaches to IP risk management can protect their exit potential and create ...

MUNICH, March 31, 2025 /PRNewswire/ -- The European Patent Office (EPO) published its annual Patent Index 2024 today, revealing that a total of 199,264 European patent applications were filed last ...

Four Japanese companies among the EPO's Top 25 applicants worldwide.

Shares of CureVac climbed after the European Patent Office confirmed the validity of a patent that has been the subject of a lawsuit filed by BioNTech. The stock rose 7% to $2.99 on Friday. Shares ...

CureVac's amended patent survives BioNTech's challenge as EPO upholds validity. A German court will decide on infringement in ...

CureVac (CVAC) announced that the European Patent Office has confirmed the validity of the company’s European patent EP 3 708 668 B1 subject to ...

The European Patent Office declared a patent owned by CureVac , valid, after a challenge from drugmaker BioNTech , the company said on Thursday.

On Tuesday, the European Patent Office (EPO) published the Patent Index 2024, the latest edition of the EU patent agency’s ...

(Alliance News) - Solvonis Therapeutics PLC on Wednesday reported "positive progress" on its European patent application for the Awkn-Sdn-14 programme.